p87 and p101 Subunits Are Distinct Regulators Determining Class IB Phosphoinositide 3-Kinase (PI3K) Specificity

被引:35
|
作者
Shymanets, Aliaksei
Prajwal
Bucher, Kirsten
Beer-Hammer, Sandra
Harteneck, Christian
Nuernberg, Bernd [1 ]
机构
[1] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany
关键词
G-BETA-GAMMA; PROTEIN-COUPLED RECEPTORS; CATALYTIC SUBUNIT; ACTIVATION; PI3K-GAMMA; P110-BETA; ISOFORM; KINASE; ROLES; INHIBITION;
D O I
10.1074/jbc.M113.508234
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Class IB phosphoinositide 3-kinase gamma (PI3K gamma) comprises a single catalytic p110 gamma subunit, which binds to two non-catalytic subunits, p87 or p101, and controls a plethora of fundamental cellular responses. The non-catalytic subunits are assumed to be redundant adaptors for G beta gamma enabling G-protein-coupled receptor-mediated regulation of PI3K gamma. Growing experimental data provide contradictory evidence. To elucidate the roles of the non-catalytic subunits in determining the specificity of PI3K gamma, we tested the impact of p87 and p101 in heterodimeric p87-p110 gamma and p101-p110 gamma complexes on the modulation of PI3K gamma activity in vitro and in living cells. RT-PCR, biochemical, and imaging data provide four lines of evidence: (i) specific expression patterns of p87 and p101, (ii) up-regulation of p101, providing the basis to consider p87 as a protein forming a constitutively and p101 as a protein forming an inducibly expressed PI3K gamma, (iii) differences in basal and stimulated enzymatic activities, and (iv) differences in complex stability, all indicating apparent diversity within class IB PI3K gamma. In conclusion, expression and activities of PI3K gamma are modified differently by p87 and p101 in vitro and in living cells, arguing for specific regulatory roles of the non-catalytic subunits in the differentiation of PI3K gamma signaling pathways.
引用
收藏
页码:31059 / 31068
页数:10
相关论文
共 50 条
  • [31] P87PIKAP -: A novel regulatory subunit of phosphoinositide 3-kinase γ
    Voigt, P
    Schaefer, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R44 - R44
  • [32] Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements
    Bertucci, Alexandre
    Bertucci, Francois
    Goncalves, Anthony
    CANCERS, 2023, 15 (05)
  • [33] The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101
    Stephens, LR
    Eguinoa, A
    ErdjumentBromage, H
    Lui, M
    Cooke, F
    Coadwell, J
    Smrcka, AS
    Thelen, M
    Cadwallader, K
    Tempst, P
    Hawkins, PT
    CELL, 1997, 89 (01) : 105 - 114
  • [34] A bibliometric analysis of highly cited Phosphoinositide 3-Kinase (PI3K) research papers
    Ho, Yuh-Shan
    Hartley, James
    COLLNET JOURNAL OF SCIENTOMETRICS AND INFORMATION MANAGEMENT, 2020, 14 (01) : 37 - 54
  • [35] Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailability
    Kawada, Hatsuo
    Ebiike, Hirosato
    Tsukazaki, Masao
    Yamamoto, Shun
    Koyama, Kohei
    Nakamura, Mitsuaki
    Morikami, Kenji
    Yoshinari, Kiyoshi
    Yoshida, Miyuki
    Ogawa, Kotaro
    Shinma, Nobuo
    Tsukuda, Takuo
    Ohwada, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) : 7650 - 7660
  • [36] Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα
    Kim, Jinhee
    Hong, Seunghee
    Hong, Sungwoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 6977 - 6981
  • [37] Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Wu, Peng
    Su, Yi
    Guan, Xianghong
    Liu, Xiaowen
    Zhang, Jiankang
    Dong, Xiaowu
    Huang, Wenhai
    Hu, Yongzhou
    PLOS ONE, 2012, 7 (08):
  • [38] Elucidation of the mechanism of phosphoinositide 3-kinase (PI3K) inhibitor mediated dyserythropoiesis in rodents
    Ledieu, D.
    Bunn, I.
    Rosner, E.
    Wuersch, K.
    Hopfer, U.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S282 - S283
  • [39] Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor
    Chandrasekhar, Jayaraman
    Dick, Ryan
    Van Veldhuizen, Joshua
    Koditek, David
    Lepist, Eve-Irene
    McGrath, Mary E.
    Patel, Leena
    Phillips, Gary
    Sedillo, Kassandra
    Somoza, John R.
    Therrien, Joseph
    Till, Nicholas A.
    Treiberg, Jennifer
    Villasenor, Armando G.
    Zherebina, Yelena
    Perreault, Stephane
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (15) : 6858 - 6868
  • [40] The class II phosphoinositide 3-kinase PI3K-C2β regulates cell migration by a PtdIns(3)P dependent mechanism
    Domin, J
    Harper, L
    Aubyn, D
    Wheeler, M
    Florey, O
    Haskard, D
    Yuan, M
    Zicha, D
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (03) : 452 - 462